
	Three Months Ended July 31,				Nine Months Ended July 31,
	2026		2025		2026		2025
Numerator:
Net (loss) income attributable to Mission Produce (in millions)	$	(6.5)	$	14.7	$	(14.4)	$	21.7
Denominator:
Weighted average shares of common stock outstanding, used in computing basic earnings per share	82,847,263		70,618,199		74,801,017		70,819,280
Effect of dilutive stock options	—		—		—		—
Effect of dilutive RSUs	—		199,736		—		204,983
Effect of dilutive PSUs	—		220,119		—		197,237
Weighted average shares of common stock outstanding, used in computing diluted earnings per share	82,847,263		71,038,054		74,801,017		71,221,500
Earnings per share
Basic	$	(0.08)	$	0.21	$	(0.19)	$	0.31
Diluted	$	(0.08)	$	0.21	$	(0.19)	$	0.30

On January 21, 2026, our Board of Directors approved the adoption of a limited duration stockholder rights plan (the “Rights Plan”). Under the plan, one preferred stock purchase right will be distributed for each share of common stock held by stockholders of record on February 4, 2026. Under certain circumstances, each right will entitle stockholders to buy one one-hundredth of a share of newly-created Series A Junior Participating Preferred Stock of the Company at an exercise price of $63.00. The Company’s Board of Directors may redeem the rights at $0.01 per right at any time before a person or group has acquired 15% or more of the outstanding common stock. Additionally, at any time after a person or group becomes an acquiring person and before such person or group acquires 50% or more of the outstanding common stock, the Board of Directors may exchange the outstanding rights (other than those held by the acquiring person, which will be void) for shares of common stock at an exchange rate of one share of common stock per right, subject to adjustment. Subject to limited exceptions, if a person or group acquires 15% or more of the Company’s common stock (including shares that are synthetically owned pursuant to derivative transactions or ownership of derivative securities) or announces a tender offer and the consummation of that offer would result in such ownership (we refer to such a person or group as an “acquiring person”), each right will entitle its holder to purchase, at the right’s then-current exercise price, a number of shares of common stock having a market value at that time of two times the right’s exercise price. Rights held by the acquiring person will become void and will not be exercisable. If the Company is acquired in a merger or other business combination transaction that has not been approved by the Board of Directors after the rights become exercisable, each right will entitle its holder to purchase, at the right’s then-current exercise price, a number of shares of the acquiring company’s common stock having a market value at that time of two times the right’s exercise price.

On June 3, 2026, the Board of Directors approved a stock repurchase program, which permits the Company to repurchase up to $100 million of shares of the Company’s common stock over the next 36 months, effective June 3, 2026 (the “2026 Program”). The 2026 Program replaces the Company’s previous common stock repurchase program adopted in September 2023, which would have expired in September 2026 with approximately $11.2 million remaining. The shares may be repurchased from time to time in open market and/or pursuant to Rule 10b5-1 trading plans in such quantities and at such prices as may be authorized by certain designated officers of the Company. Share repurchases were $7.2 million and $9.4 million for the three and nine months ended July 31, 2026, respectively. No repurchases were made during the three months ended July 31, 2025, and $5.5 million of shares were repurchased for the nine months ended July 31, 2025.